Clinical Immunology Society (CIS)

2018 Annual Meeting: Immune Deficiency and Dysregulation North American Conference

Mark your calendars for the 2018 Annual Meeting!

On behalf of the Clinical Immunology Society (CIS), we invite you to attend the 2018 Annual Meeting: Immune Deficiency and Dysregulation North American Conference taking place April 26 – 29, 2018 at The Sheraton Centre Toronto in Toronto, Canada.

CIS is the key inter-disciplinary organization for the field of clinical immunology and is devoted to fostering developments in the science and practice of clinical immunology. The mission of CIS is to facilitate education, translational research and novel approaches to therapy in clinical immunology and to promote excellence in the care of patients with immunologic/inflammatory disorders.

Abstract submission for the 2018 CIS Annual Meeting will open on September 12, 2017. Notification of selected Abstracts will take place in mid-January 2018.

The Annual Meeting and Update in PID pre-conference will provide a venue for the presentation of the newest immune deficiency diseases and the pathogenesis of these defects in molecular terms. The substance of the conference will be cutting edge clinical and basic science research.

Join us for this momentous occasion that promises to be one of the best conferences on primary immunodeficiency. We look forward to seeing you in Toronto!



2018 Annual Meeting Program Committee

Roshini Sarah Abraham, PhD - Mayo Clinic
Troy R. Torgerson, MD, PhD - University of Washington

Megan Cooper, MD, PhD - Washington University in St. Louis
Alexandra F. Freeman, MD - NIH
Elie Haddad, MD, PhD - CHU Ste-Justine, University of Montreal
Sergio D. Rosenzweig, MD -  NIH
Mikko Seppanen, MD, PhD - Helsinki University Central Hospital
Nicola Wright, MD - Alberta Children's Hospital